Psoriasis Clinical Trial
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Summary
The main purpose of this study is to determine the efficacy and safety of LY3972406 in adult participants with moderate-to-severe plaque psoriasis.
Eligibility Criteria
Inclusion Criteria:
Have moderate-to-severe chronic plaque psoriasis for at least 6 months prior to baseline
Have venous access sufficient to allow for blood sampling
Are able to swallow oral medication
Agree to skin biopsies
Exclusion Criteria:
Have any other skin conditions, excluding plaque psoriasis
Have a current or recent acute, active infection
Have manifestations of other autoimmune diseases, such as systemic lupus erythematosus.
Are lactating or breastfeeding women
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 10 Locations for this study
Los Angeles California, 90045, United States More Info
Principal Investigator
Santa Monica California, 90404, United States More Info
Principal Investigator
Coral Gables Florida, 33134, United States More Info
Principal Investigator
Winter Park Florida, 32789, United States More Info
Principal Investigator
East Windsor New Jersey, 08520, United States More Info
Principal Investigator
Kenilworth New Jersey, 07033, United States More Info
Principal Investigator
Winston-Salem North Carolina, 27103, United States More Info
Principal Investigator
Camp Hill Pennsylvania, 17011, United States More Info
Principal Investigator
Houston Texas, 77004, United States More Info
Principal Investigator
Houston Texas, 77056, United States More Info
Principal Investigator
How clear is this clinincal trial information?